+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global Dyspepsia Drug Market by Type (Functional Dyspepsia, Organic Dyspepsia), Drug Type (Acid Reducer, Antacids, Antibiotics), Distribution Channel - Forecast 2024-2030- Product Image
Global Dyspepsia Drug Market by Type (Functional Dyspepsia, Organic Dyspepsia), Drug Type (Acid Reducer, Antacids, Antibiotics), Distribution Channel - Forecast 2024-2030- Product Image
Sale

Global Dyspepsia Drug Market by Type (Functional Dyspepsia, Organic Dyspepsia), Drug Type (Acid Reducer, Antacids, Antibiotics), Distribution Channel - Forecast 2024-2030

  • PDF Icon

    Report

  • 183 Pages
  • May 2024
  • Region: Global
  • 360iResearch™
  • ID: 5968213
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Dyspepsia Drug Market size was estimated at USD 8.58 billion in 2023, USD 9.01 billion in 2024, and is expected to grow at a CAGR of 5.12% to reach USD 12.18 billion by 2030.

The dyspepsia drug market includes all pharmaceuticals used in the treatment of dyspepsia, commonly known as indigestion, identified by chronic or recurrent pain in the upper abdomen, a feeling of discomfort, bloating, and nausea, which may or may not be related to meals. Rising global incidences of dyspepsia, driven by dietary habits, stress, and the aging population, significantly contribute to the demand for effective treatment solutions. Improved research in gastrointestinal pharmacotherapy has led to the development of more effective and faster-acting drugs, enhancing patient outcomes. Enhanced healthcare infrastructure, along with growing awareness of treatment options among populations, boosts the market growth.

However, potential adverse effects associated with long-term use of certain dyspepsia drugs, such as Proton-pump inhibitor (PPIs), can deter their usage and affect market growth. Significant investment required for new drug development and risk of failure in clinical trials are major barriers to entry and innovation in the market. Moreover, growing interest in exploring combination therapies that can address multiple symptoms or provide a comprehensive treatment regimen, thus improving patient adherence and outcomes. Advances in genetic and molecular profiling can lead to more personalized treatment approaches, optimizing therapeutic effectiveness and minimizing side effects.

Regional Insights

In the Americas region, pharmaceutical and healthcare sectors are advancing with ongoing innovations and research in dyspepsia drugs. The Americas market is characterized by strong regulations, which ensure the availability of effective and safe treatments. Canada offers a sophisticated healthcare landscape with a more precautionary approach towards drug approval which ensures drugs entering the market are highly vetted. European countries benefit from collective regulations under the European Medicines Agency (EMA), which streamlines drug approval processes. Lifestyle changes and an increasing elderly population contribute to the growing need for dyspepsia drugs in the region.

The Middle East region shows increasing healthcare expenditure and growing awareness about gastrointestinal diseases, contributing to the market growth. The African region is more focused on accessibility and affordability, with efforts aimed at making treatments available to a more significant portion of the population through governmental initiatives. The Asia Pacific region observed a significant surge in the prevalence of dyspepsia, primarily due to changes in dietary habits and increasing stress levels. Countries such as China, Japan, and India are heavily investing in healthcare infrastructure and research to address healthcare issues. With vast populations, India and China present a diverse market with increasing awareness and demand for over-the-counter and prescription treatments for gastrointestinal issues. Japan's aging population is a notable factor contributing to the market growth, observing a preference for high-quality and precisely formulated dyspepsia medications.

Market Trends by Segment

  • Type: Wide occurrence of functional dyspepsia with the shift towards more personalized drugs
  • Drug Type: Growing utilization of proton pump inhibitors and H2 receptor blockers for dyspepsia treatment

Industry Insights

  • Market Dynamics
  • Market Disruption Analysis
  • Porter’s Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis
  • FPNV Positioning Matrix
  • Market Share Analysis
  • Strategy Analysis and Recommendations

Recent Developments

Breakthrough FDA Approval, Phathom Pharmaceuticals Unveils VOQUEZNA for Erosive GERD Treatment

Phathom Pharmaceuticals Inc., specializing in GI disease solutions, has received FDA approval for VOQUEZNA (vonoprazan) in both 10 mg and 20 mg tablets, introducing a significant advancement in the treatment of Erosive GERD for adults. This development provides a fresh treatment option for the roughly 20 million Americans suffering from this severe form of acid reflux, addressing a critical need unmet by existing therapies.

Launch of Upsher-Smith's Famotidine for Oral Suspension, A Strategic Move in the U.S. Generic Drug Market

Upsher-Smith Laboratories, LLC, in collaboration with Appco Pharma LLC, has introduced Famotidine for Oral Suspension, USP to the U.S. market. Upsher-Smith, renowned for its commitment to quality and consistent supply, offers this FDA-approved medication to provide an alternative treatment for conditions addressed by famotidine.

Marksans Pharma Secures USFDA Approval for Generic Famotidine Tablets

Marksans Pharma Ltd. has announced receiving the final approval from the U.S. Food and Drug Administration (USFDA) for its generic Famotidine tablets, used in treating acid indigestion and heartburn. The company intends to expand its over-the-counter gastrointestinal portfolio with this product, addressing a significant therapeutic need that emerged following the withdrawal of Ranitidine to better serve customers and fill a vital market gap in antacid therapies.

Key Company Profiles

The report delves into recent significant developments in the Dyspepsia Drug Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, ANI Pharmaceuticals, Inc., AstraZeneca PLC, Bayer AG, Cadila Pharmaceuticals, Dr Reddy’s Laboratories Ltd, Haleon PLC, Intas Pharmaceuticals Ltd., Lupin Ltd., Mankind Pharma, Pfizer Inc., Prestige Consumer Healthcare Inc., Procter & Gamble Company, Salix Pharmaceuticals, Inc. by Valeant Pharmaceuticals International, Sanofi SA, Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Limited, Themis Medicare Ltd., and Torrent Pharmaceuticals Ltd.

This research report offers invaluable insights into various crucial aspects of the Dyspepsia Drug Market:

  1. Market Penetration: This section thoroughly overviews the current market landscape, incorporating detailed data from key industry players.
  2. Market Development: The report examines potential growth prospects in emerging markets and assesses expansion opportunities in mature segments.
  3. Market Diversification: This includes detailed information on recent product launches, untapped geographic regions, recent industry developments, and strategic investments.
  4. Competitive Assessment & Intelligence: An in-depth analysis of the competitive landscape is conducted, covering market share, strategic approaches, product range, certifications, regulatory approvals, patent analysis, technology developments, and advancements in the manufacturing capabilities of leading market players.
  5. Product Development & Innovation: This section offers insights into upcoming technologies, research and development efforts, and notable advancements in product innovation.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current market size and projected growth?
  2. Which products, segments, applications, and regions offer promising investment opportunities?
  3. What are the prevailing technology trends and regulatory frameworks?
  4. What is the market share and positioning of the leading vendors?
  5. What revenue sources and strategic opportunities do vendors in the market consider when deciding to enter or exit?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Surging prevalence of Dyspepsia worldwide
5.1.1.2. Government policies favoring faster drug approval processes
5.1.1.3. Investment in improved drug delivery and packaging technologies
5.1.2. Restraints
5.1.2.1. Product recall and safety concerns
5.1.3. Opportunities
5.1.3.1. Expansion through collaborative development and public-private partnerships
5.1.3.2. Advancements in research and development for enhanced drug efficacy
5.1.4. Challenges
5.1.4.1. Availability of the counterfeit drugs
5.2. Market Segmentation Analysis
5.2.1. Type: Wide occurrence of functional dyspepsia with the shift towards more personalized drugs
5.2.2. Drug Type: Growing utilization of proton pump inhibitors and H2 receptor blockers for dyspepsia treatment
5.3. Market Disruption Analysis
5.4. Porter’s Five Forces Analysis
5.4.1. Threat of New Entrants
5.4.2. Threat of Substitutes
5.4.3. Bargaining Power of Customers
5.4.4. Bargaining Power of Suppliers
5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis
6. Dyspepsia Drug Market, by Type
6.1. Introduction
6.2. Functional Dyspepsia
6.3. Organic Dyspepsia
7. Dyspepsia Drug Market, by Drug Type
7.1. Introduction
7.2. Acid Reducer
7.3. Antacids
7.4. Antibiotics
7.5. Anticonvulsant
7.6. Antidepressants
7.7. Cimetidine
7.8. Famotidine
7.9. H2 Antagonist
7.10. Nizatidine
7.11. Prokinetic agent
7.12. Proton-pump Inhibitor
7.13. Rabeprazole
7.14. Zantac
8. Dyspepsia Drug Market, by Distribution Channel
8.1. Introduction
8.2. Hospital Pharmacies
8.3. Online Pharmacies
8.4. Retail Pharmacies
9. Americas Dyspepsia Drug Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Dyspepsia Drug Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Dyspepsia Drug Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.3.1. Breakthrough FDA Approval, Phathom Pharmaceuticals Unveils VOQUEZNA for Erosive GERD Treatment
12.3.2. Launch of Upsher-Smith's Famotidine for Oral Suspension, A Strategic Move in the U.S. Generic Drug Market
12.3.3. Marksans Pharma Secures USFDA Approval for Generic Famotidine Tablets
12.4. Strategy Analysis & Recommendation
13. Competitive Portfolio
13.1. Key Company Profiles
13.2. Key Product Portfolio
List of Figures
FIGURE 1. DYSPEPSIA DRUG MARKET RESEARCH PROCESS
FIGURE 2. DYSPEPSIA DRUG MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL DYSPEPSIA DRUG MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL DYSPEPSIA DRUG MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL DYSPEPSIA DRUG MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. DYSPEPSIA DRUG MARKET DYNAMICS
FIGURE 7. GLOBAL DYSPEPSIA DRUG MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 8. GLOBAL DYSPEPSIA DRUG MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL DYSPEPSIA DRUG MARKET SIZE, BY DRUG TYPE, 2023 VS 2030 (%)
FIGURE 10. GLOBAL DYSPEPSIA DRUG MARKET SIZE, BY DRUG TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL DYSPEPSIA DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
FIGURE 12. GLOBAL DYSPEPSIA DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS DYSPEPSIA DRUG MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS DYSPEPSIA DRUG MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES DYSPEPSIA DRUG MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES DYSPEPSIA DRUG MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC DYSPEPSIA DRUG MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC DYSPEPSIA DRUG MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA DYSPEPSIA DRUG MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA DYSPEPSIA DRUG MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. DYSPEPSIA DRUG MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 22. DYSPEPSIA DRUG MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. DYSPEPSIA DRUG MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL DYSPEPSIA DRUG MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL DYSPEPSIA DRUG MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL DYSPEPSIA DRUG MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL DYSPEPSIA DRUG MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL DYSPEPSIA DRUG MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL DYSPEPSIA DRUG MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL DYSPEPSIA DRUG MARKET SIZE, BY FUNCTIONAL DYSPEPSIA, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL DYSPEPSIA DRUG MARKET SIZE, BY FUNCTIONAL DYSPEPSIA, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL DYSPEPSIA DRUG MARKET SIZE, BY ORGANIC DYSPEPSIA, BY REGION, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL DYSPEPSIA DRUG MARKET SIZE, BY ORGANIC DYSPEPSIA, BY REGION, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL DYSPEPSIA DRUG MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL DYSPEPSIA DRUG MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL DYSPEPSIA DRUG MARKET SIZE, BY ACID REDUCER, BY REGION, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL DYSPEPSIA DRUG MARKET SIZE, BY ACID REDUCER, BY REGION, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL DYSPEPSIA DRUG MARKET SIZE, BY ANTACIDS, BY REGION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL DYSPEPSIA DRUG MARKET SIZE, BY ANTACIDS, BY REGION, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL DYSPEPSIA DRUG MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL DYSPEPSIA DRUG MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL DYSPEPSIA DRUG MARKET SIZE, BY ANTICONVULSANT, BY REGION, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL DYSPEPSIA DRUG MARKET SIZE, BY ANTICONVULSANT, BY REGION, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL DYSPEPSIA DRUG MARKET SIZE, BY ANTIDEPRESSANTS, BY REGION, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL DYSPEPSIA DRUG MARKET SIZE, BY ANTIDEPRESSANTS, BY REGION, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL DYSPEPSIA DRUG MARKET SIZE, BY CIMETIDINE, BY REGION, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL DYSPEPSIA DRUG MARKET SIZE, BY CIMETIDINE, BY REGION, 2024-2030 (USD MILLION)
TABLE 27. GLOBAL DYSPEPSIA DRUG MARKET SIZE, BY FAMOTIDINE, BY REGION, 2018-2023 (USD MILLION)
TABLE 28. GLOBAL DYSPEPSIA DRUG MARKET SIZE, BY FAMOTIDINE, BY REGION, 2024-2030 (USD MILLION)
TABLE 29. GLOBAL DYSPEPSIA DRUG MARKET SIZE, BY H2 ANTAGONIST, BY REGION, 2018-2023 (USD MILLION)
TABLE 30. GLOBAL DYSPEPSIA DRUG MARKET SIZE, BY H2 ANTAGONIST, BY REGION, 2024-2030 (USD MILLION)
TABLE 31. GLOBAL DYSPEPSIA DRUG MARKET SIZE, BY NIZATIDINE, BY REGION, 2018-2023 (USD MILLION)
TABLE 32. GLOBAL DYSPEPSIA DRUG MARKET SIZE, BY NIZATIDINE, BY REGION, 2024-2030 (USD MILLION)
TABLE 33. GLOBAL DYSPEPSIA DRUG MARKET SIZE, BY PROKINETIC AGENT, BY REGION, 2018-2023 (USD MILLION)
TABLE 34. GLOBAL DYSPEPSIA DRUG MARKET SIZE, BY PROKINETIC AGENT, BY REGION, 2024-2030 (USD MILLION)
TABLE 35. GLOBAL DYSPEPSIA DRUG MARKET SIZE, BY PROTON-PUMP INHIBITOR, BY REGION, 2018-2023 (USD MILLION)
TABLE 36. GLOBAL DYSPEPSIA DRUG MARKET SIZE, BY PROTON-PUMP INHIBITOR, BY REGION, 2024-2030 (USD MILLION)
TABLE 37. GLOBAL DYSPEPSIA DRUG MARKET SIZE, BY RABEPRAZOLE, BY REGION, 2018-2023 (USD MILLION)
TABLE 38. GLOBAL DYSPEPSIA DRUG MARKET SIZE, BY RABEPRAZOLE, BY REGION, 2024-2030 (USD MILLION)
TABLE 39. GLOBAL DYSPEPSIA DRUG MARKET SIZE, BY ZANTAC, BY REGION, 2018-2023 (USD MILLION)
TABLE 40. GLOBAL DYSPEPSIA DRUG MARKET SIZE, BY ZANTAC, BY REGION, 2024-2030 (USD MILLION)
TABLE 41. GLOBAL DYSPEPSIA DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 42. GLOBAL DYSPEPSIA DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 43. GLOBAL DYSPEPSIA DRUG MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 44. GLOBAL DYSPEPSIA DRUG MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 45. GLOBAL DYSPEPSIA DRUG MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 46. GLOBAL DYSPEPSIA DRUG MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 47. GLOBAL DYSPEPSIA DRUG MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 48. GLOBAL DYSPEPSIA DRUG MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 49. AMERICAS DYSPEPSIA DRUG MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 50. AMERICAS DYSPEPSIA DRUG MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 51. AMERICAS DYSPEPSIA DRUG MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 52. AMERICAS DYSPEPSIA DRUG MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 53. AMERICAS DYSPEPSIA DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 54. AMERICAS DYSPEPSIA DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 55. AMERICAS DYSPEPSIA DRUG MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 56. AMERICAS DYSPEPSIA DRUG MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 57. ARGENTINA DYSPEPSIA DRUG MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 58. ARGENTINA DYSPEPSIA DRUG MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 59. ARGENTINA DYSPEPSIA DRUG MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 60. ARGENTINA DYSPEPSIA DRUG MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 61. ARGENTINA DYSPEPSIA DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 62. ARGENTINA DYSPEPSIA DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 63. BRAZIL DYSPEPSIA DRUG MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 64. BRAZIL DYSPEPSIA DRUG MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 65. BRAZIL DYSPEPSIA DRUG MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 66. BRAZIL DYSPEPSIA DRUG MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 67. BRAZIL DYSPEPSIA DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 68. BRAZIL DYSPEPSIA DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 69. CANADA DYSPEPSIA DRUG MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 70. CANADA DYSPEPSIA DRUG MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 71. CANADA DYSPEPSIA DRUG MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 72. CANADA DYSPEPSIA DRUG MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 73. CANADA DYSPEPSIA DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 74. CANADA DYSPEPSIA DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 75. MEXICO DYSPEPSIA DRUG MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 76. MEXICO DYSPEPSIA DRUG MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 77. MEXICO DYSPEPSIA DRUG MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 78. MEXICO DYSPEPSIA DRUG MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 79. MEXICO DYSPEPSIA DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 80. MEXICO DYSPEPSIA DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 81. UNITED STATES DYSPEPSIA DRUG MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 82. UNITED STATES DYSPEPSIA DRUG MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 83. UNITED STATES DYSPEPSIA DRUG MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 84. UNITED STATES DYSPEPSIA DRUG MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 85. UNITED STATES DYSPEPSIA DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 86. UNITED STATES DYSPEPSIA DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 87. UNITED STATES DYSPEPSIA DRUG MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 88. UNITED STATES DYSPEPSIA DRUG MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 89. ASIA-PACIFIC DYSPEPSIA DRUG MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 90. ASIA-PACIFIC DYSPEPSIA DRUG MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 91. ASIA-PACIFIC DYSPEPSIA DRUG MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 92. ASIA-PACIFIC DYSPEPSIA DRUG MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 93. ASIA-PACIFIC DYSPEPSIA DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 94. ASIA-PACIFIC DYSPEPSIA DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 95. ASIA-PACIFIC DYSPEPSIA DRUG MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 96. ASIA-PACIFIC DYSPEPSIA DRUG MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 97. AUSTRALIA DYSPEPSIA DRUG MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 98. AUSTRALIA DYSPEPSIA DRUG MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 99. AUSTRALIA DYSPEPSIA DRUG MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 100. AUSTRALIA DYSPEPSIA DRUG MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 101. AUSTRALIA DYSPEPSIA DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 102. AUSTRALIA DYSPEPSIA DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 103. CHINA DYSPEPSIA DRUG MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 104. CHINA DYSPEPSIA DRUG MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 105. CHINA DYSPEPSIA DRUG MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 106. CHINA DYSPEPSIA DRUG MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 107. CHINA DYSPEPSIA DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 108. CHINA DYSPEPSIA DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 109. INDIA DYSPEPSIA DRUG MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 110. INDIA DYSPEPSIA DRUG MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 111. INDIA DYSPEPSIA DRUG MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 112. INDIA DYSPEPSIA DRUG MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 113. INDIA DYSPEPSIA DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 114. INDIA DYSPEPSIA DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 115. INDONESIA DYSPEPSIA DRUG MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 116. INDONESIA DYSPEPSIA DRUG MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 117. INDONESIA DYSPEPSIA DRUG MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 118. INDONESIA DYSPEPSIA DRUG MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 119. INDONESIA DYSPEPSIA DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 120. INDONESIA DYSPEPSIA DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 121. JAPAN DYSPEPSIA DRUG MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 122. JAPAN DYSPEPSIA DRUG MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 123. JAPAN DYSPEPSIA DRUG MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 124. JAPAN DYSPEPSIA DRUG MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 125. JAPAN DYSPEPSIA DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 126. JAPAN DYSPEPSIA DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 127. MALAYSIA DYSPEPSIA DRUG MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 128. MALAYSIA DYSPEPSIA DRUG MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 129. MALAYSIA DYSPEPSIA DRUG MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 130. MALAYSIA DYSPEPSIA DRUG MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 131. MALAYSIA DYSPEPSIA DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 132. MALAYSIA DYSPEPSIA DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 133. PHILIPPINES DYSPEPSIA DRUG MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 134. PHILIPPINES DYSPEPSIA DRUG MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 135. PHILIPPINES DYSPEPSIA DRUG MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 136. PHILIPPINES DYSPEPSIA DRUG MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 137. PHILIPPINES DYSPEPSIA DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 138. PHILIPPINES DYSPEPSIA DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 139. SINGAPORE DYSPEPSIA DRUG MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 140. SINGAPORE DYSPEPSIA DRUG MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 141. SINGAPORE DYSPEPSIA DRUG MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 142. SINGAPORE DYSPEPSIA DRUG MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 143. SINGAPORE DYSPEPSIA DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 144. SINGAPORE DYSPEPSIA DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 145. SOUTH KOREA DYSPEPSIA DRUG MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 146. SOUTH KOREA DYSPEPSIA DRUG MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 147. SOUTH KOREA DYSPEPSIA DRUG MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 148. SOUTH KOREA DYSPEPSIA DRUG MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 149. SOUTH KOREA DYSPEPSIA DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 150. SOUTH KOREA DYSPEPSIA DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 151. TAIWAN DYSPEPSIA DRUG MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 152. TAIWAN DYSPEPSIA DRUG MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 153. TAIWAN DYSPEPSIA DRUG MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 154. TAIWAN DYSPEPSIA DRUG MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 155. TAIWAN DYSPEPSIA DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 156. TAIWAN DYSPEPSIA DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 157. THAILAND DYSPEPSIA DRUG MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 158. THAILAND DYSPEPSIA DRUG MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 159. THAILAND DYSPEPSIA DRUG MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 160. THAILAND DYSPEPSIA DRUG MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 161. THAILAND DYSPEPSIA DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 162. THAILAND DYSPEPSIA DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 163. VIETNAM DYSPEPSIA DRUG MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 164. VIETNAM DYSPEPSIA DRUG MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 165. VIETNAM DYSPEPSIA DRUG MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 166. VIETNAM DYSPEPSIA DRUG MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 167. VIETNAM DYSPEPSIA DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 168. VIETNAM DYSPEPSIA DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 169. EUROPE, MIDDLE EAST & AFRICA DYSPEPSIA DRUG MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 170. EUROPE, MIDDLE EAST & AFRICA DYSPEPSIA DRUG MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA DYSPEPSIA DRUG MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA DYSPEPSIA DRUG MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA DYSPEPSIA DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA DYSPEPSIA DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA DYSPEPSIA DRUG MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA DYSPEPSIA DRUG MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 177. DENMARK DYSPEPSIA DRUG MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 178. DENMARK DYSPEPSIA DRUG MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 179. DENMARK DYSPEPSIA DRUG MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 180. DENMARK DYSPEPSIA DRUG MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 181. DENMARK DYSPEPSIA DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 182. DENMARK DYSPEPSIA DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 183. EGYPT DYSPEPSIA DRUG MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 184. EGYPT DYSPEPSIA DRUG MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 185. EGYPT DYSPEPSIA DRUG MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 186. EGYPT DYSPEPSIA DRUG MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 187. EGYPT DYSPEPSIA DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 188. EGYPT DYSPEPSIA DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 189. FINLAND DYSPEPSIA DRUG MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 190. FINLAND DYSPEPSIA DRUG MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 191. FINLAND DYSPEPSIA DRUG MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 192. FINLAND DYSPEPSIA DRUG MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 193. FINLAND DYSPEPSIA DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 194. FINLAND DYSPEPSIA DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 195. FRANCE DYSPEPSIA DRUG MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 196. FRANCE DYSPEPSIA DRUG MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 197. FRANCE DYSPEPSIA DRUG MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 198. FRANCE DYSPEPSIA DRUG MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 199. FRANCE DYSPEPSIA DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 200. FRANCE DYSPEPSIA DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 201. GERMANY DYSPEPSIA DRUG MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 202. GERMANY DYSPEPSIA DRUG MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 203. GERMANY DYSPEPSIA DRUG MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 204. GERMANY DYSPEPSIA DRUG MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 205. GERMANY DYSPEPSIA DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 206. GERMANY DYSPEPSIA DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 207. ISRAEL DYSPEPSIA DRUG MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 208. ISRAEL DYSPEPSIA DRUG MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 209. ISRAEL DYSPEPSIA DRUG MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 210. ISRAEL DYSPEPSIA DRUG MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 211. ISRAEL DYSPEPSIA DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 212. ISRAEL DYSPEPSIA DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 213. ITALY DYSPEPSIA DRUG MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 214. ITALY DYSPEPSIA DRUG MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 215. ITALY DYSPEPSIA DRUG MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 216. ITALY DYSPEPSIA DRUG MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 217. ITALY DYSPEPSIA DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 218. ITALY DYSPEPSIA DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 219. NETHERLANDS DYSPEPSIA DRUG MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 220. NETHERLANDS DYSPEPSIA DRUG MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 221. NETHERLANDS DYSPEPSIA DRUG MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 222. NETHERLANDS DYSPEPSIA DRUG MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 223. NETHERLANDS DYSPEPSIA DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 224. NETHERLANDS DYSPEPSIA DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 225. NIGERIA DYSPEPSIA DRUG MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 226. NIGERIA DYSPEPSIA DRUG MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 227. NIGERIA DYSPEPSIA DRUG MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 228. NIGERIA DYSPEPSIA DRUG MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 229. NIGERIA DYSPEPSIA DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 230. NIGERIA DYSPEPSIA DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 231. NORWAY DYSPEPSIA DRUG MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 232. NORWAY DYSPEPSIA DRUG MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 233. NORWAY DYSPEPSIA DRUG MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 234. NORWAY DYSPEPSIA DRUG MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 235. NORWAY DYSPEPSIA DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 236. NORWAY DYSPEPSIA DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 237. POLAND DYSPEPSIA DRUG MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 238. POLAND DYSPEPSIA DRUG MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 239. POLAND DYSPEPSIA DRUG MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 240. POLAND DYSPEPSIA DRUG MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 241. POLAND DYSPEPSIA DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 242. POLAND DYSPEPSIA DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 243. QATAR DYSPEPSIA DRUG MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 244. QATAR DYSPEPSIA DRUG MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 245. QATAR DYSPEPSIA DRUG MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 246. QATAR DYSPEPSIA DRUG MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 247. QATAR DYSPEPSIA DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 248. QATAR DYSPEPSIA DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 249. RUSSIA DYSPEPSIA DRUG MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 250. RUSSIA DYSPEPSIA DRUG MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 251. RUSSIA DYSPEPSIA DRUG MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 252. RUSSIA DYSPEPSIA DRUG MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 253. RUSSIA DYSPEPSIA DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 254. RUSSIA DYSPEPSIA DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 255. SAUDI ARABIA DYSPEPSIA DRUG MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 256. SAUDI ARABIA DYSPEPSIA DRUG MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 257. SAUDI ARABIA DYSPEPSIA DRUG MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 258. SAUDI ARABIA DYSPEPSIA DRUG MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 259. SAUDI ARABIA DYSPEPSIA DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 260. SAUDI ARABIA DYSPEPSIA DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 261. SOUTH AFRICA DYSPEPSIA DRUG MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 262. SOUTH AFRICA DYSPEPSIA DRUG MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 263. SOUTH AFRICA DYSPEPSIA DRUG MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 264. SOUTH AFRICA DYSPEPSIA DRUG MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 265. SOUTH AFRICA DYSPEPSIA DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 266. SOUTH AFRICA DYSPEPSIA DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 267. SPAIN DYSPEPSIA DRUG MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 268. SPAIN DYSPEPSIA DRUG MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 269. SPAIN DYSPEPSIA DRUG MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 270. SPAIN DYSPEPSIA DRUG MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 271. SPAIN DYSPEPSIA DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 272. SPAIN DYSPEPSIA DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 273. SWEDEN DYSPEPSIA DRUG MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 274. SWEDEN DYSPEPSIA DRUG MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 275. SWEDEN DYSPEPSIA DRUG MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 276. SWEDEN DYSPEPSIA DRUG MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 277. SWEDEN DYSPEPSIA DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 278. SWEDEN DYSPEPSIA DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 279. SWITZERLAND DYSPEPSIA DRUG MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 280. SWITZERLAND DYSPEPSIA DRUG MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 281. SWITZERLAND DYSPEPSIA DRUG MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 282. SWITZERLAND DYSPEPSIA DRUG MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 283. SWITZERLAND DYSPEPSIA DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 284. SWITZERLAND DYSPEPSIA DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 285. TURKEY DYSPEPSIA DRUG MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 286. TURKEY DYSPEPSIA DRUG MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 287. TURKEY DYSPEPSIA DRUG MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 288. TURKEY DYSPEPSIA DRUG MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 289. TURKEY DYSPEPSIA DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 290. TURKEY DYSPEPSIA DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 291. UNITED ARAB EMIRATES DYSPEPSIA DRUG MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 292. UNITED ARAB EMIRATES DYSPEPSIA DRUG MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 293. UNITED ARAB EMIRATES DYSPEPSIA DRUG MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 294. UNITED ARAB EMIRATES DYSPEPSIA DRUG MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 295. UNITED ARAB EMIRATES DYSPEPSIA DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 296. UNITED ARAB EMIRATES DYSPEPSIA DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 297. UNITED KINGDOM DYSPEPSIA DRUG MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 298. UNITED KINGDOM DYSPEPSIA DRUG MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 299. UNITED KINGDOM DYSPEPSIA DRUG MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 300. UNITED KINGDOM DYSPEPSIA DRUG MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 301. UNITED KINGDOM DYSPEPSIA DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 302. UNITED KINGDOM DYSPEPSIA DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 303. DYSPEPSIA DRUG MARKET SHARE, BY KEY PLAYER, 2023
TABLE 304. DYSPEPSIA DRUG MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

  • Abbott Laboratories
  • ANI Pharmaceuticals, Inc.
  • AstraZeneca PLC
  • Bayer AG
  • Cadila Pharmaceuticals
  • Dr Reddy’s Laboratories Ltd
  • Haleon PLC
  • Intas Pharmaceuticals Ltd.
  • Lupin Ltd.
  • Mankind Pharma
  • Pfizer Inc.
  • Prestige Consumer Healthcare Inc.
  • Procter & Gamble Company
  • Salix Pharmaceuticals, Inc. by Valeant Pharmaceuticals International
  • Sanofi SA
  • Sun Pharmaceutical Industries Ltd.
  • Takeda Pharmaceutical Company Limited
  • Themis Medicare Ltd.
  • Torrent Pharmaceuticals Ltd.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages183
PublishedMay 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 9.01 Billion
Forecasted Market Value ( USD ) by 2030 $ 12.18 Billion
Compound Annual Growth Rate5.1%
Regions CoveredGlobal
No. of Companies Mentioned19

Related Topics

Related Reports

Global Antacids Market by Drug Class (Acid Neutralizers, H2 Antagonist, Promotility Agents), Formulation (Liquid, Powder, Tablet), Indication, Distribution Channel - Forecast 2024-2030 - Product Image

Global Antacids Market by Drug Class (Acid Neutralizers, H2 Antagonist, Promotility Agents), Formulation (Liquid, Powder, Tablet), Indication, Distribution Channel - Forecast 2024-2030

  • Report
  • 192 Pages
  • Global
From
Antacids Global Market Report 2024 - Product Image

Antacids Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Antacids Market Size, Share & Trends Analysis Report By Type (Tablet, Liquid), By End-use (Retail Pharmacy, Hospital Pharmacy), By Region, And Segment Forecasts, 2023 - 2030 - Product Image

Antacids Market Size, Share & Trends Analysis Report By Type (Tablet, Liquid), By End-use (Retail Pharmacy, Hospital Pharmacy), By Region, And Segment Forecasts, 2023 - 2030

  • Report
  • 90 Pages
  • Global
From
Antacids Market - Global Industry Size, Share, Trends, Opportunity, & Forecast 2018-2028 - Product Image

Antacids Market - Global Industry Size, Share, Trends, Opportunity, & Forecast 2018-2028

  • Report
  • 189 Pages
  • Global
From
Antacid Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Antacid Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 91 Pages
  • Global
From

About the Market

Dyspepsia is a condition characterized by upper abdominal pain, bloating, and nausea. Dyspepsia drugs are used to treat the symptoms of dyspepsia, as well as other gastrointestinal disorders. These drugs are typically divided into two categories: antacids and proton pump inhibitors (PPIs). Antacids are used to neutralize stomach acid and reduce symptoms of heartburn and indigestion. PPIs are used to reduce the amount of acid produced in the stomach, which can help reduce symptoms of acid reflux and ulcers. The dyspepsia drug market is a subset of the larger gastrointestinal drug market. This market is driven by the increasing prevalence of gastrointestinal disorders, such as irritable bowel syndrome, gastroesophageal reflux disease, and peptic ulcer disease. Additionally, the rising demand for over-the-counter medications and the increasing availability of generic drugs are expected to drive the growth of the dyspepsia drug market. Some companies in the dyspepsia drug market include Pfizer, GlaxoSmithKline, AstraZeneca, Merck, and Novartis. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.